JohnCheretis

Associate

Washington + 1.202.879.3424

John Cheretis concentrates his practice on advising clients in complex international trade, national security, and government contracting matters. He has assisted clients with evaluating and structuring cross-border investments and supply chains, as well as navigating investigations and regulatory proceedings.

John has significant experience advising clients with respect to U.S. foreign direct investment regulations and national security considerations. John has represented clients in investment reviews conducted by the Committee on Foreign Investment in the United States (CFIUS) and in structuring transactions to mitigate CFIUS risks. He has also counseled companies in a variety of U.S. customs matters, including classification, valuation, and country of origin determinations, as well as compliance with Withhold Release Orders and other import restrictions administered by Customs and Border Protection (CBP). John has also represented clients in seeking tariff relief in proceedings before the United States Trade Representative (USTR).

John has also assisted clients with understanding and complying with various economic sanctions programs administered by the Office of Foreign Assets Control (OFAC) and export control issues arising under the Export Administration Regulations (EAR) and International Traffic in Arms Regulations (ITAR).

John maintains an active pro bono practice. He has represented U.S. veterans in obtaining disability benefits as well as individuals seeking asylum and other forms of immigration relief.

Experience

  • PureCycle Technologies combines with Roth CH Acquisition I Co.Jones Day advised PureCycle Technologies LLC ("PureCycle") in its business combination with Roth CH Acquisition I Co. ("Roth SPAC"), a publicly-traded special purpose acquisition corporation backed by Roth Capital Partners and Craig-Hallum Capital Group, and Roth CH Acquisition I Co. Parent Corp., a wholly owned subsidiary of Roth CH ("Holdings"), among others.
  • STERIS to acquire Cantel Medical for $3.6 billionJones Day is advising STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • DataBank acquires zColo for $1.4 billionJones Day advised DataBank, a leading provider of enterprise-class colocation, connectivity, and managed services, in connection with the acquisition and financing of zColo, including certain U.S. and European data center assets, from Zayo Group Holdings, Inc. for $1.4 billion.
  • STERIS acquires Key Surgical for approximately $850 millionJones Day advised STERIS plc (NYSE: STE) in the $850 million acquisition of Key Surgical, a leading global provider of sterile processing, operating room, and endoscopy products, and a portfolio company of Water Street Healthcare Partners, LLC.
  • UPMC prevails in trial before Commonwealth Court of PennsylvaniaJones Day won a bench trial on behalf of the University of Pittsburgh Medical Center ("UPMC"), one of the nation's preeminent integrated healthcare systems.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.